null Psychologist Tina Montreuil is making a difference

RI-MUHC researcher invited to provide expert testimony to the House of Commons regarding her project, the Montreal Antenatal Well-Being Study on Women’s Mental Health and Child Outcomes

April 12, 2024

A scientist in Child Health and Human Development Program at the RI-MUHC, Tina Montreuil, PhD, has been recognized by the Centre for Addiction and Mental Health as one of Canada’s Difference Makers : 150 Leading Canadians for Mental Health.

This honour led to Prof. Montreuil’s selection as an expert witness, invited to present before Canada’s parliament.

Tina Montreuil, PhD, is a scientist in Child Health and Human Development Program at the RI-MUHC.
Tina Montreuil, PhD, is a scientist in Child Health and Human Development Program at the RI-MUHC.

On April 8, 2024, she went before the House of Commons of Canada to address the Standing Committee on Health Studies Issues (HESA), a group mandated by Health Canada for issues including bills and regulations. Prof. Montreuil discussed the findings of the Montreal Antenatal Well-Being Study, one of the largest studies in Canada seeking to better understand why some women are more likely than others to experience anxiety and depression during and after pregnancy.

Prof. Montreuil was also invited to address questions from the HESA regarding the current state of research and clinical practice in women’s health across the lifespan. With other nationwide experts, she highlighted the importance of preventive care and the promotion of health from the pre-conception to postpartum periods. She also presented the results of a report led by the Quebec Alliance for Perinatal Mental Health on the Quebec Perinatal Mental Health Sector Mapping, which included government recommendations.

Congratulations to Prof. Montreuil for this honour!

About the Montreal Antenatal Well-Being Study

The Montreal Antenatal Well-Being Study is led by Tina Montreuil, PhD, Kieran O’Donnell, PhD, and a team of researchers at McGill University, in collaboration with St. Mary's Hospital Centre, the McGill University Health Centre, and CHU Ste-Justine. Funding for the study is provided by the Canada First Research Excellence Fund, the Healthy Brains, Health Lives initiative at McGill University, a Brains and Behaviour Research Foundation NARSAD Young Investigator Grant, the Ferring COVID-19 Investigational Grant in Reproductive Medicine and Maternal Health, a CIFAR Fellowship in the Child and Brain Development Program, the Chamandy Foundation, and the Montreal Children’s Hospital Foundation.